Skip to main content
Equibles

Nantahala Capital Management, LLC

Position in AURA — Aura Biosciences, Inc.

CIK 1472322 New Canaan, CT
Back to AURA Full portfolio

Position in AURA

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$20,952,313
+$6,784,921 QoQ
Shares Held
2,951,030
+39.4% QoQ
Ownership
2.85%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#12
of 146 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. AURA ranks #8 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SVRA
Savara Inc
 6,976,810 $42,977,149
2 AVTX
Avalo Therapeutics, Inc.
 1,862,250 $34,414,380
3 LBRX
Lb Pharmaceuticals Inc
 1,052,894 $34,171,674
4 ABEO
Abeona Therapeutics Inc.
 5,136,490 $31,743,508
5 ZVRA
Zevra Therapeutics, Inc.
 1,797,476 $25,775,805
6 MLYS
Mineralys Therapeutics, Inc.
 820,481 $22,136,577
7 QURE
uniQure N.V.
 455,660 $20,987,699
8 AURA
Aura Biosciences, Inc.
This page 		2,951,030 $20,952,313

All Filings in AURA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,952,313 2,951,030
2026-03-31 $14,167,392 2,117,697
2025-12-31 $11,541,448 2,117,697
2025-09-30 $13,087,367 2,117,697
2025-06-30 $13,256,783 2,117,697
2025-03-31 $7,428,704 1,267,697
2024-12-31 $10,439,687 1,270,035
2024-09-30 $11,316,011 1,270,035
2024-06-30 $9,601,464 1,270,035
2024-03-31 $10,376,601 1,321,860
2023-12-31 $11,711,679 1,321,860
2023-09-30 $6,672,711 743,892
2023-06-30 $9,921,063 803,325
2023-03-31 $7,827,178 843,446
2022-12-31 $8,386,885 798,751
2022-09-30 $6,953,803 383,764
2022-06-30 $4,863,356 343,215
2022-03-31 $6,643,780 301,990
2021-12-31 $1,683,499 99,146